![Nederlof Michel](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Nederlof Michel
Keine laufenden Positionen mehr
Karriereverlauf von Nederlof Michel
Ehemalige bekannte Positionen von Nederlof Michel
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Cernostics, Inc.
![]() Cernostics, Inc. Medical SpecialtiesHealth Technology Cernostics, Inc. develops and commercializes cancer diagnostic tests. Its technology is based on a systems approach to evaluating tissues via anatomic pathology and simultaneously evaluates immune, stromal, stem cell and tumor biomarkers on a single slide while preserving tissue structure. The company was founded in 2008 by Michel Nederlof and Rebecca Critchley-Thorne and is headquartered in Pittsburgh, PA. | Technik-/Wissenschafts-/F&E-Leiter | 16.06.2011 | - |
Gründer | 15.06.2011 | - | |
Präsident | 16.06.2011 | - |
Statistik
International
Vereinigte Staaten | 2 |
Operativ
Chief Tech/Sci/R&D Officer | 1 |
Founder | 1 |
President | 1 |
Sektoral
Health Technology | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Private Unternehmen | 1 |
---|---|
Cernostics, Inc.
![]() Cernostics, Inc. Medical SpecialtiesHealth Technology Cernostics, Inc. develops and commercializes cancer diagnostic tests. Its technology is based on a systems approach to evaluating tissues via anatomic pathology and simultaneously evaluates immune, stromal, stem cell and tumor biomarkers on a single slide while preserving tissue structure. The company was founded in 2008 by Michel Nederlof and Rebecca Critchley-Thorne and is headquartered in Pittsburgh, PA. | Health Technology |
- Börse
- Insiders
- Nederlof Michel
- Erfahrung